Can the Werfen GEM Hemochron 100 activated clotting time be used to monitor anticoagulation in prolonged baseline activated partial thromboplastin time?
During open heart surgery, patients receive a blood-thinning medicine called heparin to stop blood clots from forming in the heart-lung machine. Surgical teams must measure blood clotting levels closely to keep patients safe. Usually, blood samples are sent to a hospital laboratory, which takes valuable time. This study tests a handheld device called the GEM Hemochron 100. It checks blood clotting at the patient's bedside within the operating theatre, giving doctors results much faster. Researchers are testing how well this machine works for people whose blood naturally takes longer than usual to clot. Taking part involves a simple finger-prick test and small blood samples taken before and during surgery. The study will not alter your planned operation or treatment. It aims to help doctors make heart surgery safer and more efficient for future NHS patients.
At a glance
What is this study about?
When a person undergoes open heart surgery, a heart-lung machine temporarily takes over the work of their heart and lungs. To stop blood from clotting inside this machine, patients are given a powerful blood thinner called heparin. Doctors must monitor how thin the blood is throughout the operation so they can give the exact right dose.
Some people naturally have blood that takes longer to clot, which shows up on routine pre-surgery blood tests known as a prolonged aPTT. For these patients, doctors currently send blood samples across the hospital to a central laboratory to check their heparin levels. Waiting for these lab results takes time during an operation.
This study looks at an alternative testing machine called the GEM Hemochron 100 ACT. This compact device can be kept right inside the operating theatre, testing a drop of blood in just a few minutes. Researchers want to find out whether this bedside device is as accurate and dependable as the main hospital laboratory for patients with naturally slower clotting times.
By comparing results from the bedside device with standard laboratory tests, the study team hopes to create new, safer guidelines for heart surgery teams. If successful, this could help doctors get vital information much faster, improving patient safety during major operations.
Key takeaways
- Tests a fast bedside blood monitor (GEM Hemochron 100) inside the operating theatre.
- Aims to make blood thinner monitoring quicker and safer during open heart surgery.
- Open to adults having open heart surgery or visiting a haematology clinic with slow clotting times.
- Requires only a simple finger-prick test and small blood samples during standard care.
- Does not alter your planned operation, medicines, or standard NHS treatment.
Who may be eligible?
You may be able to join this study if you are 18 or older and are scheduled for open heart surgery using a heart-lung machine at the Lancashire Cardiac Centre. You may also be eligible if you are attending the Lancashire Haematology Centre for tests because your blood naturally takes longer to clot. A control group of heart surgery patients with normal clotting times will also take part.
To take part, you must be able to understand the study details and give your own consent. You should not be taking regular blood-thinning medicines at the exact time your first baseline test is done.
You will not be able to participate if you are under 18, cannot give informed consent, are currently taking blood thinners, or need a language translator to complete the study visits.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or over.
- I am having open heart surgery, or attending a haematology clinic for slow clotting checks.
- I am not currently taking regular blood-thinning medication.
- I am able to give informed consent in English without a translator.
- I am being treated at Blackpool Teaching Hospitals NHS Foundation Trust.
What does participation involve?
If you take part, your normal hospital care will continue as planned without any delays. Before your procedure or during your clinic visit, a member of the research team will take a tiny drop of blood from your fingertip to test on the bedside machine. They will also take a routine blood sample from your arm to test in the laboratory.
If you are having heart surgery, the surgical team will take additional small blood samples from your existing line every 30 minutes during your operation. These samples will be tested on both the bedside machine and sent to the laboratory so the team can compare the results.
There are no extra medicines to take and no extra hospital visits required beyond your normal surgery or clinic schedule. The study only involves testing blood samples taken before and during your planned hospital care.
Potential risks and benefits
Locations (1)
- Blackpool Teaching Hospitals NHS Foundation TrustCity onlyBlackpool, England
Common questions
Will taking part delay my heart surgery?
No. The blood samples are taken as part of your normal pre-surgery checks and during the operation itself, so your surgery will proceed on schedule.
Is the new bedside machine safe?
Yes. The machine only tests a small drop of your blood outside your body. It does not touch you directly during surgery and will not interfere with your operation.
Does this trial involve testing a new medicine?
No. The study is only testing a diagnostic blood-testing machine. You will receive the standard blood-thinning medicine (heparin) that all heart surgery patients receive.
Will having extra blood taken make me weaker?
No. The total amount of blood collected for the study is very small and will not affect your recovery or overall strength.
What happens if I decide not to take part?
Taking part is entirely your choice. If you decide not to join, your surgery and NHS care will carry on exactly as normal.
How to find out more
Claire Rowlandson
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.